Related references
Note: Only part of the references are listed.Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis
Eneida Santos de Oliveira et al.
FAMILIAL CANCER (2016)
Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care
Rossella Graffeo et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation
Kelvin C. Andrade et al.
GENETICS AND MOLECULAR BIOLOGY (2016)
Rapid Detection Method for the Four Most Common CHEK2 Mutations Based on Melting Profile Analysis
Pawel Borun et al.
MOLECULAR DIAGNOSIS & THERAPY (2015)
Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
Felipe C. Silva et al.
BMC MEDICAL GENETICS (2014)
Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
Juliana Giacomazzi et al.
PLOS ONE (2014)
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families
Nathalia M. Cury et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2014)
Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
Dirce Maria Carraro et al.
PLOS ONE (2013)
The CHEK2 I157T Variant and Breast Cancer Susceptibility: A Systematic Review and Meta-analysis
Chuan Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer
Haeyoung Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil
Crisle Vignol Dillenburg et al.
GENETICS AND MOLECULAR BIOLOGY (2012)
The R337H mutation in TP53 and breast cancer in Brazil
Magda C. B. Gomes et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2012)
Breast and Ovarian Cancer Risk due to Prevalence of BRCA1 and BRCA2 Variants in Pakistani Population: A Pakistani Database Report
Ayesha Farooq et al.
JOURNAL OF ONCOLOGY (2011)
Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
Ingrid P. Ewald et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2011)
Prevalence of BRCA1 and BRCA2 Mutations in Women with Breast Carcinoma In Situ and Referred for Genetic Testing
Michael J. Hall et al.
CANCER PREVENTION RESEARCH (2010)
Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil
V. F. Esteves et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Association of the germline TP53 R337H mutation with breast cancer in southern Brazil
Juliana G. Assumpcao et al.
BMC CANCER (2008)
Detection of R337H a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil
Edenir Inez Palmero et al.
CANCER LETTERS (2008)
High-throughput amplicon scanning of the TP53 gene in breast cancer using high-resolution fluorescent melting curve analyses and automatic mutation calling
Roy Bastien et al.
HUMAN MUTATION (2008)
CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk:: Meta-analyses of 26,000 patient cases and 27,000 controls
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
Magda C. B. Gomes et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Most rare missense alleles are deleterious in humans: Implications for complex disease and association studies
Gregory V. Kryukov et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
Maria Isabel Waddington Achatz et al.
CANCER LETTERS (2007)
Association of two mutations in the CHEK2 gene with breast cancer
N Bogdanova et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Share Paper
